Ingineeon GmbH
PrivateCompany Overview
Ingineeon GmbH operates in Healthcare & Life Sciences and is based in Germany. It was founded in 2024.
Ingineeon GmbH is a biotechnology company that develops first-in-class cytokine-based immunotherapeutics for the treatment of infectious diseases, inflammatory diseases, and oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ingineeon GmbH Comparables
Compare Ingineeon GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bright Peak Therapeutics | 79% | |
| Anaveon | 79% | |
| Asher Biotherapeutics | 77% |
For institutional investors. Book with your work email.
Ingineeon GmbH Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Ingineeon GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ingineeon GmbH's valuation, stock price, and market status.
Is Ingineeon GmbH a public or private company?
Ingineeon GmbH is a private company.
What is the current stock price of Ingineeon GmbH?
Ingineeon GmbH is a private company, so its shares have no public market price. Caplight tracks Ingineeon GmbH's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ingineeon GmbH worth (valuation)?
Valuation information for Ingineeon GmbH is not publicly available.
Can I buy Ingineeon GmbH stock?
Ingineeon GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ingineeon GmbH's last funding round?
Funding round information for Ingineeon GmbH is not publicly available.
Who are the main investors in Ingineeon GmbH?
Investor information for Ingineeon GmbH is not publicly disclosed.
Will Ingineeon GmbH IPO soon?
No public IPO plans have been announced for Ingineeon GmbH.
How can I track Ingineeon GmbH secondary market activity?
Caplight tracks bids, offers, and trades in Ingineeon GmbH's shares on secondary markets.